Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome

✍ Scribed by Thornik Reimer; Michael H. Shaw; Luigi Franchi; Cevayir Coban; Ken J. Ishii; Shizuo Akira; Toshihiro Horii; Ana Rodriguez; Gabriel Núñez

• Book ID: 102167021
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 237 KB
• Volume: 40
• Category: Article
• ISSN: 0014-2980
• DOI: 10.1002/eji.200939996

✦ Synopsis

Abstract

Cerebral malaria is the most severe complication of Plasmodium falciparum infection in humans and the pathogenesis is still unclear. Using the P. berghei ANKA infection model of mice, we investigated a potential involvement of Nlrp3 and the inflammasome in the pathogenesis of cerebral malaria. Nlrp3 mRNA expression was upregulated in brain endothelial cells after exposure to P. berghei ANKA. Although β‐hematin, a synthetic compound of the parasites heme polymer hemozoin, induced the release of IL‐1β in macrophages through Nlrp3, we did not obtain evidence for a role of IL‐1β in vivo. Nlrp3 knock‐out mice displayed a delayed onset of cerebral malaria; however, mice deficient in caspase‐1, the adaptor protein ASC or the IL‐1 receptor succumbed as WT mice. These results indicate that the role of Nlrp3 in experimental cerebral malaria is independent of the inflammasome and the IL‐1 receptor pathway.